During that time, 797 (23 percent) of those participants developed dementia, and 637 of them developed Alzheimer's [5]. The following year in 2016, Indiana University School of Medicine Researchers ...

A group of Japanese researchers have developed a set of simple questions to detect Alzheimer's disease and mild cognitive ...

Half a million people in England will be diagnosed with dementia by the end of this year, NHS forecasts show ...

Alzheimer's wonder drugs aren't yet delivering on their promise. American researchers have come up with a brand new idea, a ...

President-elect Donald Trump on Friday nominated Dr. Marty Makary to lead the Food and Drug Administration, selecting a ...

Neuroinflammation can be caused by a range of factors, including stress, and can lead to irreversible consequences like ...

Exploring the challenges faced by Black experts in the field of aging and dementia. The need for diversity in research and ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the drug cost regulator deemed its benefits were too small to justify the price.

There's no cure for this disease, but now there is some hope for people and their families who are battling the illness in ...

EXCLUSIVE: UCL researchers argue that loss of brain volume may in fact be a sign that the treatments are working.

Long-term use of cardiovascular drugs may reduce dementia risk in older adults by up to 25%, while antiplatelet drugs could ...